Legislative Activity

The Reducing Regulatory Burdens Act of 2025 aims to streamline pesticide regulation by generally exempting legally authorized pesticide applications from needing separate Clean Water Act discharge permits. This change applies when authorized pesticides or their residues enter navigable waters from a specific discharge point. However, the exemption does not apply if the discharge violates FIFRA rules, involves certain stormwater runoff, or originates from industrial processes or vessels.

The END CELLS Act amends the Communications Act of 1934 to prohibit the introduction, possession, or transfer of unauthorized wireless communication devices in jails and prisons. This legislation establishes significant civil and criminal penalties for violations involving contraband electronics in detention facilities. The law specifically targets actions that violate existing federal or state rules regarding such devices within correctional settings. These new rules apply to all conduct occurring after the date the Act is officially enacted.

This resolution strongly condemns the rise of antisemitism in the United States and around the world. It specifically honors the memory of Yaron Lischinsky and Sarah Milgrim, who were tragically murdered while promoting peace. Ultimately, Congress reaffirms its commitment to combating all forms of hate and ensuring the vigorous enforcement of laws protecting religious freedom.

This bill expresses the disapproval of Congress, under the Congressional Review Act, of a specific rule issued by the Environmental Protection Agency (EPA). The rejected rule concerned the National Emission Standards for Hazardous Air Pollutants for the rubber tire manufacturing industry. As a result of this disapproval, the EPA's proposed standards will not take effect.

The Improving Seniors’ Timely Access to Care Act of 2025 aims to streamline and modernize the prior authorization process within Medicare Advantage plans. This bill mandates the adoption of electronic prior authorization systems and significantly increases transparency regarding approval rates and decision times starting in 2027. Furthermore, it establishes new enrollee protections and grants the Secretary authority to enforce faster decision timeframes for medical services.

The COUNTER Act enhances the Department of Defense's authority to neutralize threats from unmanned aircraft systems targeting U.S. assets. This legislation delegates specific response powers and updates mitigation rules for drone threats. Crucially, it exempts sensitive information regarding these counter-drone technologies and procedures from public disclosure under the Freedom of Information Act. The bill also adjusts several deadlines and clarifies the applicability of certain federal laws when operating overseas to counter these threats.

This bill disapproves of and nullifies the Department of Energy's rule on energy conservation standards for commercial refrigerators, freezers, and refrigerator-freezers.

This bill, the Access to Prescription Digital Therapeutics Act of 2025, establishes coverage and payment pathways for FDA-cleared Prescription Digital Therapeutics (PDTs) under Medicare Part B starting in 2026. It mandates the Secretary to develop payment methodologies based on private payer rates and requires manufacturers to report utilization and pricing data to ensure fair reimbursement. Furthermore, the Act expands Medicaid's authority to cover these software-based medical treatments when prescribed to beneficiaries.

The Research Advancing to Market Production for Innovators Act aims to accelerate the commercialization of federally funded small business research. It enhances the SBIR/STTR programs by requiring commercialization expertise in proposal reviews and speeding up review timelines. The bill also establishes Technology Commercialization Officials within agencies and mandates detailed reporting on the market success of award recipients. Finally, it increases flexibility for technical assistance funding and provides prioritized patent examination services through the USPTO for awardees.

This resolution expresses the strong support of Congress for designating May 2025 as Motorcycle Safety Awareness Month. It acknowledges the significant role motorcyclists play in transportation while highlighting the critical need for increased safety awareness. The bill encourages proper rider training, the use of protective gear, and mutual road safety between motorcyclists and other drivers.

The Transparency and Honesty in Energy Regulations Act establishes strict definitions for various social cost metrics related to greenhouse gas emissions. The core provision of the bill prohibits federal agencies from using these specific social cost estimates—including the social cost of carbon, methane, and nitrous oxide—in their required cost-benefit analyses for rulemaking and official actions. Furthermore, the Act mandates that federal agencies must report to Congress on all past uses of these climate-related cost figures in their decision-making processes since 2009.

The Ensuring Community Access to Pharmacist Services Act expands Medicare Part B coverage to include services provided by pharmacists starting January 1, 2026. This coverage is specifically for testing or treatment related to COVID-19, the flu, RSV, strep throat, or during a declared public health emergency. The bill outlines payment structures, generally covering 80% of the cost, and prohibits pharmacists from balance billing Medicare patients for these covered services.

The Rural Patient Monitoring Access Act aims to improve access to remote patient monitoring (RPM) for rural Medicare beneficiaries. It establishes a minimum payment floor for the geographic indices used to calculate practice expense and malpractice costs for RPM services starting in 2026. Furthermore, the bill sets new quality requirements for RPM providers to qualify for Medicare payment, including real-time clinical availability and data interoperability. Finally, it mandates a future report analyzing the actual cost savings generated by these enhanced RPM services.

The "Prove It Act of 2025" aims to reduce regulatory burdens on small businesses by requiring agencies to consider indirect costs when creating new rules, allowing small businesses to petition for reviews of agency certifications, and mandating agencies to publish guidance documents and allow comments on rules with a significant economic impact on small businesses. Additionally, the Act amends the periodic review process for rules, requiring agencies to consider indirect costs and providing a mechanism for the Small Business Administration to address rules not reviewed within a 10-year period. The Act specifies that no additional funds will be allocated for its implementation.

The Seniors’ Access to Critical Medications Act of 2025 temporarily modifies the physician self-referral prohibition (Stark Law) to allow physician practices to dispense certain Medicare Part D prescription drugs directly to their patients between 2026 and 2030. This exception is subject to specific conditions regarding prescribing, patient history, and dispensing location. The bill also mandates a GAO study to examine trends in physician office drug dispensing and makes a minor adjustment to the allocation for the Medicare Improvement Fund.

This bill amends Medicare rules to cap the out-of-pocket coinsurance amount beneficiaries must pay for certain services provided in an Ambulatory Surgical Center (ASC). If the standard ASC coinsurance exceeds the annual inpatient hospital deductible, the beneficiary's cost will be limited to that deductible amount. The Secretary will cover the difference owed to the ASC.

The VARIANCE Act temporarily allows commercial trucks hauling specific dry bulk goods, like grain or gravel, to exceed standard weight limits on individual axles or axle groups by up to 110 percent. This change only applies to axle weight distribution and does not permit trucks to exceed the overall maximum gross vehicle weight limit. The exception is strictly for unpackaged, homogeneous, non-liquid materials transported in specialized trailers.

The SOAR Act of 2025 aims to significantly reform Medicare access to supplemental oxygen by removing it from the competitive bidding program and establishing new payment rates. The bill also mandates clearer documentation requirements for medical necessity using electronic templates and restores clinical judgment in claim audits. Finally, it establishes specific rights for oxygen beneficiaries and improves reimbursement for respiratory therapists.

The Enhanced Iran Sanctions Act of 2025 aims to prevent Iran from obtaining nuclear weapons and countering its support for terrorism by imposing sanctions on those involved in Iran's energy sector and those who provide financial support for its destabilizing activities. It mandates sanctions on foreign entities involved in processing, exporting, or selling Iranian oil, gas, and petrochemicals, while also establishing an interagency working group to coordinate and enforce these sanctions. The Act also amends existing legislation to require the identification of individuals involved in sanctionable activities or sanctions evasion related to Iranian oil and gas sales.

This bill, the Protecting America’s Strategic Petroleum Reserve from China Act, strictly prohibits the sale or release of oil from the U.S. Strategic Petroleum Reserve (SPR) to any entity owned, controlled, or influenced by the Chinese Communist Party. Furthermore, it prevents the sale of SPR products to non-Chinese buyers if those products are intended for export to the People's Republic of China. The legislation aims to safeguard U.S. energy reserves from benefiting the Chinese government.